Aligos Therapeutics, Inc. Operating Lease Liability
Aligos Therapeutics, Inc. (ALGS) had Operating Lease Liability of $5.11 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-05
- 2025-12-31: Operating Lease, Liability $5.11M.
- 2024-12-31: Operating Lease, Liability $8.22M.
- 2023-12-31: Operating Lease, Liability $10.90M.
- 2022-12-31: Operating Lease, Liability $12.24M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $5.11M 10-K · filed 2026-03-05 |
| 2024-12-31 | $8.22M 10-K · filed 2025-03-10 |
| 2023-12-31 | $10.90M 10-K · filed 2024-03-12 |
| 2022-12-31 | $12.24M 10-K · filed 2023-03-09 |
| 2021-12-31 | $14.06M 10-K · filed 2022-03-10 |
| 2021-09-30 | $12.29M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $12.37M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $12.70M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $12.81M 10-K · filed 2021-03-23 |
| 2020-09-30 | $13.14M 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |